Trigonostemon
Trigonostemon
Trigonostemon is a plant with traditional medicine roots, though specific uses are not documented. Scientific research has shown that Trigonochinene E from this plant promotes lysosomal biogenesis and autophagy in human degenerative nucleus pulposus cells, indicating potential benefits for conditions involving cell degradation. Extracts from Trigonostemon xyphophyllorides have also demonstrated significant anti-proliferative effects on renal cancer cells through the PI3K/AKT pathway, suggesting possible applications in oncology. Additionally, compounds strophiofimbrin A and B showed notable proliferation inhibition and neuroprotective effects, while PSO exhibited antiproliferative activity against renal cell carcinoma cells by inhibiting the PI3K/AKT pathway. To date, no major safety issues or drug interactions have been recorded for Trigonostemon, but further research is needed to fully understand its potential benefits and risks.
- Meilleure preuve
- D
- Précautions
- —
Information uniquement. L'usage traditionnel ne signifie pas une efficacité prouvée. Les preuves et la sécurité varient — consultez les sources citées.
Ce que dit la science
- L'étude a montré que l'extrait de Trigonostemon xyphophyllorides a montré des effets antiprolifératifs significatifs sur les cellules du cancer rénal via le chemin PI3K-AKT.
- Le trigonochène E favorise l'biosynthèse des lysosomes et augmente l'autophagie par le biais de TFEB/TFE3 dans les cellules humaines dégénératives NP.
- Deux nouveaux norditerpénoids réarrangés avec des structures tricycliques uniques ont été identifiés chez Strophioblachia fimbricalyx, montrant une certaine inhibition de la prolifération et une activité neuroprotectrice.
- PSO, un composant actif de Trigonostemon xyphophyllorides, a montré des effets antiprolifératifs puissants sur les cellules du carcinome rénal par l'inhibition du chemin PI3K/AKT.
- Deux synthèses totales de trigoxyphines K et L issues de Trigonostemon xyphophylloides sont décrites.
Frequently asked questions
What is Trigonostemon?
Trigonostemon (Trigonostemon) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Trigonostemon?
5 sourced findings are recorded for Trigonostemon; the strongest carries evidence grade D. For example: L'étude a montré que l'extrait de Trigonostemon xyphophyllorides a montré des effets antiprolifératifs significatifs sur les cellules du cancer rénal via le chemin PI3K-AKT.
How strong is the evidence for Trigonostemon?
The strongest finding for Trigonostemon carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Trigonostemon safe? What are the side effects?
No major safety issues are recorded for Trigonostemon in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Trigonostemon interact with medications?
No drug interactions are recorded for Trigonostemon in our sources. This does not rule them out — check with a pharmacist.
Is Trigonostemon a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Trigonochinene E promotes lysosomal biogenesis and enhances autophagy via TFEB/TFE3 in human degenerative NP cells against oxidative stress. literature abstract metadata
- T2 Strophiofimbrins A and B: Two Rearranged Norditerpenoids with Novel Tricyclic Carbon Skeletons from Strophioblachia fimbricalyx. literature abstract metadata
- T2 Two Total Syntheses of Trigoxyphins K and L. literature abstract metadata
- T2 Antiproliferative effects of Trigonostemon xyphophyllorides on renal cell carcinoma via the PI3K/AKT pathway. literature abstract metadata
- T2 Multi-omics analysis reveals psoralen to suppresses renal cell carcinoma through the PI3K/AKT pathway. literature abstract metadata